For high-risk patients, the method could offer a safer alternative to open-heart surgery.
Spiro Medical announced today that it closed a $67 million Series A equity financing to support its neuromodulation system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback